Corrigendum to "Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: Synergistic effect of combination with interferon-α in HepG2 2.2.15" [Antiviral Res. 72 (2006) 162-165] (DOI:10.1016/j.antiviral.2006.05.011);Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: Synergistic effect of combination with interferon-α in HepG2 2.2.15

Antiviral Research

Volumn 72, Issue 2, 2006, Pages 162-165

  Gu, Chang Qing ^a   Li, Jun Wen ^a   Chao, Fu Huan ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

Author keywords

Antiviral; Combination; Grifola frondosa; Hepatitis B virus; Interferon

Indexed keywords

GRIFOLA FRONDOSA EXTRACT; PLANT EXTRACT; RECOMBINANT ALPHA INTERFERON; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; HEPATITIS B VIRUS; IC 50; IMMUNOTHERAPY; NONHUMAN; PHYTOTHERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INHIBITION;

GRIFOLA FRONDOSA; HEPATITIS B VIRUS;

EID: 33748289971     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.09.004     Document Type: Erratum

References (22)

1. Aoki M., Tan M., Fukushima A., Hieda T., and Mikaml Y. Antiviral substances with septimic effects produced by basidiomycetes such as Fomes fomentarius. Biosci. Biotech. Biochem. 57 (1993) 178-282
2. Briolant S., Garin D., Scaramozzino N., Jouan A., and Crance J.M. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination. Antiviral Res. 61 (2004) 111-117
3. Cassady K.A., and Whitley R.J. New therapeutic approaches to the α-herpesvirus infections. J. Antimicrob. Chemother. 39 (1997) 119-128
4. Chen R.W., Piiparinen H., Seppanen M., Koskela P., Sarna S., and Lappalainen M. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J. Med. Virol. 65 (2001) 250-256
5. Chen N., Wu Z.J., Lin Q.Y., and Xie L.H. Purification and partial characterization of a protein inhibitor of tobacco mosaic virus infection from Maitake (Grifola frondosa). Prog. Biochem. Biophys. 31 (2004) 283-286
6. Davis M.G., Wilson J.E., VanDraanen N.A., Miller W.H., Freeman G.A., Daluge S.M., Boyd F.L., Aulabaugh A.E., Painter G.R., and Boone L.R. DNA polymerase activity of hepatitis B virus particles:differential inhibition by l-enantiomers of nucleotide analogs. Antiviral Res. 30 (1996) 133-145
7. Gaillard R.K., Barnard J., Lopez V., Hodges P., Bourne E., Johnson L., Allen M.I., Condreay P., Miller W.H., and Condreay L.D. Analysis of wild-type and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity. Antimicrob. Agents. Chemother. 46 (2002) 1005-1013
8. Hayashi Y., and Koike K. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J. Virol. 63 (1989) 2936-2940
9. Hishida I., Nanba H., and Kuroda H. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake). Chem. Pharm. Bull. 36 (1988) 1819-1827
10. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2 (2002) 395-403
11. Kodama N., Murata Y., Asakawa A., Inui A., Hayashi M., Sakai N., and Nanba H. Maitake D-fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 21 (2005) 624-629
12. Korba B.E. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res. 29 (1996) 49-51
13. Lewin S., Walters T., and Locarnini S. Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies. Antiviral Res. 55 (2002) 381-396
14. Liaw Y.F., Leung N.W., Chang T.T., Guan R., Tai D.I., Ng K.Y., Chien R.N., Dent J., Roman L., Edmundson S., and Lai C.L. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 119 (2000) 172-180
15. Liu J., Li Y.H., Xue C.F., Ding J., Gong W.D., Zhao Y., and Huang Y.X. Targeted ribonuclease can inhibit replication of hepatitis B virus. World J. Gastroenterol. 9 (2003) 295-299
16. Manesis E.K., and Hadziyannis S.J. Interferon α treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology 121 (2001) 101-109
17. Mayell M. Maitake extracts and their therapeutic potential. Altern. Med. Rev. 6 (2001) 48-60
18. Nanba H., Kodama N., Schar D., and Turner D. Effects of maitake (Grifola frondosa) glucan in HIV-infected patients. Mycoscience 41 (2000) 293-295
19. Rang A., Gunther S., and Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J. Hepatol. 31 (1999) 791-799
20. Sarkar S., Koga J., Whitley R.J., and Chatterjee S. Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1. Antiviral Res. 20 (1993) 293-303
21. Sorimachi K., Akir N., Yamazaki S., Toda S., and Yasumura Y. Anti-viral activity of water-solubilized lignin derivatives in vitro. Agric. Biol. Chem. 54 (1990) 1337-1339
22. Tochikura T.S., Nakashima H., Ohashi Y., and Yamamoto N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med. Microbiol. Immunol. 177 (1988) 235-244